Although monotherapy is generally recommended as the treatment of
choice, treatment resistance of patients with psychosis, cognitive,
mood and anxiety disorders represents a significant clinical
problem. In this context, augmentation and combination strategies
are commonly employed to address this problem. Although multiple
medication use common in psychiatric practice, reasons, efficacy
and safety for polypharmacy, and augmentative strategies have
remained unclear. It remains unclear if there is an evidence base
to support polypharmacy. Furthermore, excessive and inappropriate
use of psychotropic medications has been recognized as a public
health problem. This volume is the first comprehensive, clinically
oriented, reference on the multiple medication use to treat
psychotic, cognitive, mood and anxiety disorders.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!